ENDRA Life Sciences Inc. (NDRA) financial statements (2021 and earlier)

Company profile

Business Address 3600 GREEN COURT
ANN ARBOR, MI 48105
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7666
Cash and cash equivalents7666
Receivables   0
Inventory, net of allowances, customer advances and progress billings1000
Inventory1000
Prepaid expense0000
Other current assets0000
Total current assets:8776
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment0000
Total noncurrent assets:1100
TOTAL ASSETS:9776
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1211
Accounts payable0111
Employee-related liabilities0000
Interest and dividends payable 0  
Other undisclosed accounts payable and accrued liabilities0000
Debt 0  
Other undisclosed current liabilities0   
Total current liabilities:1211
Noncurrent Liabilities
Long-term debt and lease obligation10  
Long-term debt, excluding current maturities0   
Operating lease, liability00
Other undisclosed noncurrent liabilities(0)   
Total noncurrent liabilities:10  
Total liabilities:2211
Stockholders' equity
Stockholders' equity attributable to parent, including:7565
Common stock0000
Additional paid in capital64503423
Accumulated deficit(57)(45)(28)(18)
Other undisclosed stockholders' equity attributable to parent00  
Total stockholders' equity:7565
TOTAL LIABILITIES AND EQUITY:9776

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues  00
Revenue, net0
Cost of revenue
(Cost of Goods and Services Sold)
  (0)(0)
Other undisclosed gross profit  0 
Gross profit:  00
Operating expenses(12)(11)(9)(5)
Operating loss:(12)(11)(9)(5)
Nonoperating expense(0)(2)(1) 
Other nonoperating income (expense)0(0)(1) 
Interest and debt expense   (0)
Loss from continuing operations before equity method investments, income taxes:(12)(13)(10)(5)
Other undisclosed loss from continuing operations before income taxes   (1)
Net loss attributable to parent:(12)(13)(10)(5)
Preferred stock dividends and other adjustments(0)(4)  
Net loss available to common stockholders, diluted:(12)(18)(10)(5)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(12)(13)(10)(5)
Comprehensive loss, net of tax, attributable to parent:(12)(13)(10)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: